67 related articles for article (PubMed ID: 25541526)
1. Molecular recognition of CYP26A1 binding pockets and structure-activity relationship studies for design of potent and selective retinoic acid metabolism blocking agents.
Sun B; Song S; Hao CZ; Huang WX; Liu CC; Xie HL; Lin B; Cheng MS; Zhao DM
J Mol Graph Model; 2015 Mar; 56():10-9. PubMed ID: 25541526
[TBL] [Abstract][Full Text] [Related]
2. First chemical feature-based pharmacophore modeling of potent retinoidal retinoic acid metabolism blocking agents (RAMBAs): identification of novel RAMBA scaffolds.
Purushottamachar P; Patel JB; Gediya LK; Clement OO; Njar VC
Eur J Med Chem; 2012 Jan; 47(1):412-23. PubMed ID: 22130607
[TBL] [Abstract][Full Text] [Related]
3. Liposomal delivery of hydrophobic RAMBAs provides good bioavailability and significant enhancement of retinoic acid signalling in neuroblastoma tumour cells.
Bilip M; Shah S; Mathiyalakan M; Tagalakis AD; Hart SL; Maeshima R; Eaton S; Orford M; Irving E; Di Florio A; Simons C; Stoker AW
J Drug Target; 2020 Jul; 28(6):643-654. PubMed ID: 31903789
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of retinoic acid metabolism blocking agents (RAMBAs) on the growth of human prostate cancer cells and LNCaP prostate tumour xenografts in SCID mice.
Huynh CK; Brodie AM; Njar VC
Br J Cancer; 2006 Feb; 94(4):513-23. PubMed ID: 16449997
[TBL] [Abstract][Full Text] [Related]
5. Retinoic acid metabolism in cancer: potential feasibility of retinoic acid metabolism blocking therapy.
Osanai M; Takasawa A; Takasawa K; Kyuno D; Ono Y; Magara K
Med Mol Morphol; 2023 Mar; 56(1):1-10. PubMed ID: 36592231
[TBL] [Abstract][Full Text] [Related]
6. Metformin reduces hepatocarcinogenesis by inducing downregulation of Cyp26a1 and CD8
He W; Wang X; Chen M; Li C; Chen W; Pan L; Cui Y; Yu Z; Wu G; Yang Y; Xu M; Dong Z; Ma K; Wang J; He Z
Clin Transl Med; 2023 Nov; 13(11):e1465. PubMed ID: 37997519
[TBL] [Abstract][Full Text] [Related]
7. Structure-Function Analysis of the Essential
Padayachee T; Lamb DC; Nelson DR; Syed K
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732102
[TBL] [Abstract][Full Text] [Related]
8. The role of CYP26 enzymes in retinoic acid clearance.
Thatcher JE; Isoherranen N
Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):875-86. PubMed ID: 19519282
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of thyroid hormone and its structurally similar contaminant bisphenol S exposure on retinoid metabolism in zebrafish larval eyes.
Qiu L; Wei S; Wang Y; Zhang R; Ru S; Zhang X
Environ Int; 2023 Oct; 180():108217. PubMed ID: 37748373
[TBL] [Abstract][Full Text] [Related]
10. Pharmacophore-Based Virtual Screening of Novel Inhibitors and Docking Analysis for CYP51A from Penicillium italicum.
Yuan Y; Han R; Cao Q; Yu J; Mao J; Zhang T; Wang S; Niu Y; Liu D
Mar Drugs; 2017 Apr; 15(4):. PubMed ID: 28379163
[TBL] [Abstract][Full Text] [Related]
11. Modelling inhibition of avian aromatase by azole pesticides.
Saxena AK; Devillers J; Bhunia SS; Bro E
SAR QSAR Environ Res; 2015; 26(7-9):757-82. PubMed ID: 26535448
[TBL] [Abstract][Full Text] [Related]
12.
Facey COB; Hunsu VO; Zhang C; Osmond B; Opdenaker LM; Boman BM
Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254755
[No Abstract] [Full Text] [Related]
13. Galeon: A Biologically Active Molecule with In Silico Metabolite Prediction, In Vitro Metabolic Profiling in Rat Liver Microsomes, and In Silico Binding Mechanisms with CYP450 Isoforms.
Rahman AFMM; Yin W; Kadi AA; Jahng Y
Molecules; 2020 Dec; 25(24):. PubMed ID: 33322201
[TBL] [Abstract][Full Text] [Related]
14. 2 D - QSAR studies on CYP26A1 inhibitory activity of 1-[benzofuran-2-yl-(4-alkyl/aryl-phenyl)-methyl]- 1 H-triazoles.
Yadav M
Bioinformation; 2011; 7(8):388-92. PubMed ID: 22347780
[TBL] [Abstract][Full Text] [Related]
15. Improved Homology Model of the Human all-trans Retinoic Acid Metabolizing Enzyme CYP26A1.
Awadalla MK; Alshammari TM; Eriksson LA; Saenz-Méndez P
Molecules; 2016 Mar; 21(3):351. PubMed ID: 26999080
[TBL] [Abstract][Full Text] [Related]
16. Construction of antifungal dual-target (SE, CYP51) pharmacophore models and the discovery of novel antifungal inhibitors.
Dong Y; Liu M; Wang J; Ding Z; Sun B
RSC Adv; 2019 Aug; 9(45):26302-26314. PubMed ID: 35531010
[TBL] [Abstract][Full Text] [Related]
17. Biochemical and physiological importance of the CYP26 retinoic acid hydroxylases.
Isoherranen N; Zhong G
Pharmacol Ther; 2019 Dec; 204():107400. PubMed ID: 31419517
[TBL] [Abstract][Full Text] [Related]
18. Human cytochrome P450 enzymes 5-51 as targets of drugs and natural and environmental compounds: mechanisms, induction, and inhibition - toxic effects and benefits.
Rendic SP; Peter Guengerich F
Drug Metab Rev; 2018 Aug; 50(3):256-342. PubMed ID: 30717606
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the ligand binding site of CYP2C8 with CYP26A1 and CYP26B1: a structural basis for the identification of new inhibitors of the retinoic acid hydroxylases.
Foti RS; Diaz P; Douguet D
J Enzyme Inhib Med Chem; 2016; 31(sup2):148-161. PubMed ID: 27424662
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
